NYSE$UAMY
United States Antimony Corporation · Q3 2025 earnings
Q3 2025 earnings · · After market close
Briefing
UAMY reported Q3 2025 revenue of $42.0M, a net loss of $15.0M, diluted EPS of $30.00.
For Q3 2025, UAMY reported Revenue was $42.0M, net loss was $15.0M, diluted EPS was $30.00. The filing discusses operating performance, liquidity, and outlook in MD&A.
- Revenue $42.0M for Q3 2025.
- Net loss $15.0M.
- Diluted EPS $30.00.
Headline financials
Revenue & EPS history
United States Antimony Corporation · Revenue · Quarterly
$8.7M
Revenue by segment
United States Antimony Corporation · $6.57M total across 2 segments · Q1 2026
- Antimony$5.55M—84.5%
- Zeolite$1.02M—15.5%
Forward guidance
Outlook focuses on cash runway, pipeline milestones, and cost discipline as the company works toward profitability.
Tailwinds
- Cash and equivalents support operations into upcoming milestones.
- Clinical or product pipeline progress noted in MD&A.
Headwinds
- Ongoing operating losses and R&D spend pressure near-term earnings.
- Financing, dilution, or partnership timing may affect liquidity.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q3 2025
-0.3%
Avg return
Earnings day
-1.4%
Avg return
5 days after
+11.2%
Avg return
30 days after
22%
7 / 32 earnings
Positive
+19.0%
Q1 2024
Best reaction
-10.4%
Q4 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -3.8% | -25.5% | -29.5% | |
| Q4 2025 | -10.4% | +8.3% | +16.0% | |
| Q3 2025 | -5.6% | -7.1% | -26.5% | |
| Q2 2025 | +0.8% | +12.7% | +21.1% | |
| Q1 2025 | -7.1% | -31.9% | -11.1% | |
| Q3 2024 | -8.8% | -23.5% | +145.6% | |
| Q2 2024 | +9.1% | +15.2% | +112.1% | |
| Q1 2024 | +19.0% | +23.8% | +76.2% | |
| Q3 2023 | -3.2% | -3.2% | -22.6% | |
| Q2 2023 | +0.0% | -2.9% | -17.1% | |
| Q1 2023 | -2.8% | -2.8% | -8.3% | |
| Q3 2022 | +0.0% | -8.1% | +21.6% | |
| Q2 2022 | -4.1% | +0.0% | -14.3% | |
| Q1 2022 | +7.9% | +13.2% | +5.3% | |
| FY 2021 | -1.7% | -8.3% | -30.0% | |
| Q3 2021 | -1.1% | -16.1% | -35.6% | |
| Q2 2021 | -4.3% | -9.6% | -5.3% | |
| Q1 2021 | +0.0% | +6.8% | +27.0% | |
| Q3 2020 | +0.0% | +13.9% | +19.4% | |
| Q2 2020 | +0.0% | -12.0% | -4.0% | |
| Q1 2020 | -2.8% | -5.6% | +30.6% | |
| Q3 2019 | -4.4% | +11.1% | -17.8% | |
| Q2 2019 | -2.5% | -13.9% | -22.8% | |
| Q1 2019 | +0.0% | +5.8% | +13.5% | |
| Q3 2018 | -2.9% | +7.4% | -7.4% | |
| Q2 2018 | +0.0% | +0.0% | +17.2% | |
| Q1 2018 | +0.0% | +6.9% | +58.6% | |
| Q3 2017 | +0.0% | -8.0% | +12.0% | |
| Q2 2017 | +15.2% | +6.1% | -9.1% | |
| Q1 2017 | +4.7% | +4.7% | -7.0% | |
| Q3 2016 | -9.5% | -31.0% | -28.6% | |
| Q2 2016 | +9.7% | +29.0% | +80.6% |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro